Atrioventricular and interventricular delay optimization and response quantification in biventricular pacing: Arrival of reliable clinical algorithms and research protocols, and how to distinguish them from unreliable counterparts

Europace

Volumn 14, Issue 12, 2012, Pages 1679-1683

  Stegemann, Berthold ^a   Francis, Darrel P ^b  

^a MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EFFECTIVENESS; ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; PACEMAKER; PLETHYSMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT RESPONSE;

CARDIAC RESYNCHRONIZATION THERAPY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; THERAPY, COMPUTER-ASSISTED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84867367814     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus242     Document Type: Review

References (10)

1. Bogaard MD, Meine M, Tuinenburg AE, Maskara B, Loh P, Doevendans PA. Cardiac resynchronization therapy beyond nominal settings: who needs individual programming of the atrioventricular and interventricular delay? Europace 2012;14: 1746-53.
2. Auger D, Höke U, Bax JJ, Boersma E. Impact of AV-and VV-delay optimization in patients treated with cardiac resynchronization therapy: a meta-analysis. J Am Coll Cardiol 2012;59:E871-E871.
3. Doyle AC. The curious incident of the dog in the night-time. In: Silver Blaze (ed). The Memoirs of Sherlock Holmes. 1894. http://www.gutenberg.org/ files/834/834-h/834-h.htm#2H-4-0001.
4. Pabari PA, Willson K, Stegemann B, van Geldorp IE, Kyriacou A, Moraldo M et al. When is an optimization not an optimization? Evaluation of clinical implications of information content (signal-to-noise ratio) in optimization of cardiac resynchronization therapy, and how to measure and maximise it. Heart Fail Rev 2011;16: 277-90.
5. Turcott RG, Witteles RM, Wang PJ, Vagelos RH, Fowler MB, Ashley EA. Measurement precision in the optimization of cardiac resynchronization therapy. Circ Heart Fail 2010;3:395-404.
6. Francis DP. How to reliably deliver narrow individual-patient error bars for optimization of pacemaker AV or VV delay using a 'pick-the-highest' strategy with haemodynamic measurements. Int J Cardiol (in press) [Epub ahead of print 18 April 2012].
7. Manisty CH, Al-Hussaini A, Unsworth B, Baruah R, Pabari PA, Mayet J et al. The acute effects of changes to AV delay on Blood pressure and stroke volume: potential implications for design of pacemaker optimization protocols. Circulation: Arrhythm Electrophysiol 2012;5:122-30.
8. van Geldorp IE, Delhaas T, Hermans B, Vernooy K, Broers B, Klimusina B et al. Comparison of a non-invasive arterial pulse contour technique and echo Doppler aorta velocity-time integral on stroke volume changes in optimization of cardiac resynchronization therapy. Europace 2011;13:87-95.
9. Francis DP. Precision of a parabolic optimum calculated from noisy biological data, and implications for quantitative optimization of biventricular pacemakers (Cardiac Resynchronization Therapy). Appl Math 2011;2:1497-506.
10. Nijjer SS, Pabari A, Stegemann B, Palmieri V, Leyva F, Linde C et al. The limit of plausibility for predictors of response: application to biventricular pacing (cardiac resynchronization therapy) with systematic review and design steps for reliable research. J Am Coll Cardiol: Cardiovasc Imag 2012 (in press).